Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 30, 2026
Why Is Carvana (CVNA) Stock Down -10.69% Today?

Why Is Carvana (CVNA) Stock Down -10.69% Today?

Key Takeaways

  • Carvana (CVNA) shares tumbled approximately 10.7% in Thursday's trading session, extending a sharp after-hours selloff.
  • The primary catalyst was disappointing full-year adjusted EBITDA guidance, which landed below Wall Street consensus despite record-breaking second-quarter results.
  • Q2 revenue surged 52% year-over-year to $7.38 billion and EPS of $0.42 both exceeded analyst estimates, yet the market fixated on the weaker outlook.
  • Full-year 2026 adjusted EBITDA guidance of $2.7 billion to $3.0 billion fell short of expectations that ranged from $3 billion at the low end to as high as $4.45 billion from some analysts.
  • Broader market context: consumer discretionary stocks faced headwinds, and CVNA's steep decline stood out even within a mixed tape for the sector.
  • Traders are now watching for analyst revisions, retail unit trends in Q3, and any signs of stabilization in used-vehicle pricing.

Opening Summary

CVNA — Carvana Co., the online used-car retailer that has reshaped automotive e-commerce — saw its stock plunge approximately 10.7% on Thursday, trading near $59.23 after closing the prior session at $66.32. The selloff was triggered by the company's second-quarter 2026 earnings report, released after Wednesday's close. While Carvana delivered record quarterly revenue and earnings that topped consensus estimates, the market seized on full-year adjusted EBITDA guidance that came in significantly below the more optimistic projections circulating on Wall Street. The after-hours rout deepened in the regular session, making this one of the stock's sharpest single-day declines in recent months.

Q2 Results: A Strong Quarter Overshadowed by Weak Guidance

On the surface, Carvana's Q2 2026 numbers painted a picture of a company firing on all cylinders. Revenue reached an all-time quarterly record of $7.38 billion, a 52% increase year-over-year and well above the $6.90 billion consensus estimate. Retail units sold surged 38% to 197,325, marking the company's tenth consecutive quarter of industry-leading growth. GAAP earnings per share rose 61.5% to $0.42, exceeding the $0.36 analysts had projected. Adjusted EBITDA came in at a record $769 million.

However, gross profit per unit slipped roughly 6% from the prior-year quarter to $7,014, down $412. While management highlighted the sequential improvement, the year-over-year decline raised concerns about margin pressure in a competitive used-car market.

Guidance Disappointment Fuels the Selloff

The real problem for CVNA was the forward outlook. Management guided for full-year 2026 adjusted EBITDA in a range of $2.7 billion to $3.0 billion — up from $2.24 billion in 2025 but below the range several major banks had modeled. Deutsche Bank had reportedly anticipated $3.0 billion to $3.2 billion, while Morgan Stanley had penciled in approximately $4.45 billion. With first-half adjusted EBITDA already at roughly $1.44 billion, the guidance implies the second half will be essentially flat to only modestly higher, dashing hopes for accelerating profitability.

The company did forecast a sequential increase in retail units sold in Q3 and reaffirmed its long-term ambition of reaching three million vehicles per year with a 13.5% adjusted EBITDA margin by 2030 to 2035. But the near-term reset in expectations was enough to trigger aggressive selling.

Analyst Reactions: Price Targets Come Down

In the wake of the report, at least one prominent analyst moved quickly. Citizens analyst Andrew Boone lowered his price target on CVNA to $83 from $103 while maintaining a Buy rating. Boone acknowledged the market-beating Q2 revenue and EBITDA but noted concerns about the second-half adjusted EBITDA trajectory. He nonetheless argued the medium-term story remains intact, citing higher gas prices, selective advertising investments, and the return of financing gains to consumers. Boone continues to view Carvana as a "structural winner" in used vehicles and suggested any pullback could represent a buying opportunity.

Wall Street's consensus rating on CVNA remains a Strong Buy, based on 13 Buy and two Hold ratings, though the average price target of approximately $91.64 is likely to be revised downward as more analysts update their models following the Q2 print.

Market Context and Trading Activity

Trading volume surged dramatically, with more than 18 million shares changing hands during Wednesday's regular session — roughly double the 90-day average — and Thursday's activity remaining elevated. The stock's intraday range on Thursday stretched from approximately $55.46 to $69.41, reflecting extreme volatility as the market digested the mixed earnings picture. The decline was far steeper than the broader market and outpaced weakness in consumer discretionary peers. CVNA shares sliced through several technical levels, including the 50-day moving average, and are now trading closer to the lower end of their 52-week range after having touched a 52-week high of $97.38 in January 2026.

Year-to-date, Carvana shares are now down more than 30%, a stark reversal from the stock's meteoric rise in prior years. The company still commands a market capitalization near $47 billion, but the valuation debate has intensified as growth decelerates and margin questions persist.

What Comes Next for CVNA

Traders and investors will be closely monitoring several developments in the weeks ahead. The company's Q3 retail unit trajectory will be a critical data point to assess whether management's guidance for sequential growth is achievable. Used-vehicle wholesale pricing trends — specifically the Manheim Used Vehicle Value Index — will provide important context on margin dynamics. Additionally, the broader macroeconomic environment, including interest rates and consumer credit conditions, remains a key variable for a business that relies heavily on auto financing. While management expressed confidence in the long-term path to three million annual units, the second-half 2026 profit trajectory will be the immediate litmus test for whether this selloff represents a buying opportunity or the beginning of a deeper re-rating.

Trending AI Robots

For traders seeking to navigate volatility like today's move in CVNA, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots designed to adapt to shifting market conditions. Tickeron provides hundreds of AI trading bots that collectively cover thousands of tickers across multiple strategies, timeframes, and performance metrics. Only the strongest performers under current market conditions appear in this curated section, giving traders a focused view of which algorithmic approaches are delivering results right now. Bots vary by strategy type, holding period, and the symbols they trade. Explore the Trending AI Robots page to discover automated trading tools aligned with today's market dynamics.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CVNA

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


CVNA in upward trend: price rose above 50-day moving average on August 04, 2026

CVNA moved above its 50-day moving average on August 04, 2026 date and that indicates a change from a downward trend to an upward trend. In of 26 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 03, 2026. You may want to consider a long position or call options on CVNA as a result. In of 66 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CVNA just turned positive on August 04, 2026. Looking at past instances where CVNA's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for CVNA crossed bullishly above the 50-day moving average on August 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CVNA advanced for three days, in of 324 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVNA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CVNA broke above its upper Bollinger Band on August 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CVNA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CVNA's P/B Ratio (19.646) is very high in comparison to the industry average of (3.653). P/E Ratio (38.095) is within average values for comparable stocks, (26.281). CVNA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (0.900). CVNA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.015). CVNA's P/S Ratio (3.258) is slightly higher than the industry average of (1.228).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CVNA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Industry description

The Automotive Aftermarket consists of the manufacturing, remanufacturing, distribution, retailing, and installation of vehicle parts and accessories, after the sale of the automobile by the original equipment manufacturer (OEM) to the consumer. The aftermarket parts many not be manufactured by the OEM. According to a Technavio study, the US automotive parts aftermarket size is estimated to grow by USD 24.33 billion during 2018-2022 (CAGR 3%). Like many other industries, the automotive aftermarket is also being intensely penetrated by the digital boom. The online auto parts sales market is predicted to exceed $13B by 2020 (according to a study by Mirakl).

Market Cap

The average market capitalization across the Automotive Aftermarket Industry is 6.1B. The market cap for tickers in the group ranges from 15.95K to 79.17B. CVNA holds the highest valuation in this group at 79.17B. The lowest valued company is USAM at 15.95K.

High and low price notable news

The average weekly price growth across all stocks in the Automotive Aftermarket Industry was 2%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was -9%. RUSHA experienced the highest price growth at 48%, while UCAR experienced the biggest fall at -17%.

Volume

The average weekly volume growth across all stocks in the Automotive Aftermarket Industry was 74%. For the same stocks of the Industry, the average monthly volume growth was -57% and the average quarterly volume growth was -47%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 61
Price Growth Rating: 61
SMR Rating: 77
Profit Risk Rating: 78
Seasonality Score: -25 (-100 ... +100)
View a ticker or compare two or three
CVNA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a car dealer

Industry AutomotiveAftermarket

Profile
Details
Industry
Specialty Stores
Address
300 E. Rio Salado Parkway
Phone
+1 602 922-9866
Employees
13700
Web
https://www.carvana.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.